Indirect Calorimeter Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR (2024 - 2029) | 5.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Indirect Calorimeter Market Analysis
The Indirect Calorimeter Market is expected to register a CAGR of 5% during the forecast period.
The market is witnessing growth propelled by technological advancements in indirect calorimeters and escalating global obesity rates. Over the past few decades, obesity has surged on a global scale. For instance, as per the World Obesity Atlas 2023, across African countries, 1 in 13 men (7.76%) and 1 in 5 women (20.41%) are projected to have a body mass index of more than 30 kg by 2030. This equates to approximately 27 million men and 74 million women in the region at risk of complications of obesity by 2030. Thus, the growing burden of obesity is expected to increase demand for indirect colorimeters to measure energy, thereby boosting market growth.
Obesity is strongly associated with several serious diseases, notably cardiovascular conditions such as heart disease and stroke, diabetes, musculoskeletal issues like osteoarthritis, and a range of cancers, including endometrial, breast, ovarian, prostate, liver, gallbladder, kidney, and colon. These conditions significantly impact the quality of life and can lead to increased mortality rates. The most popular technique for measuring energy expenditure in research settings is indirect calorimetry, which has produced previously unheard-of insights into the systems that regulate energy balance in response to weight loss or growth.
Indirect calorimeters, among other medical devices, are increasingly vital in healthcare. A key challenge for companies lies in staying abreast of regulatory mandates and seamlessly integrating them into their production processes. Furthermore, the technological advancements in indirect calorimeters are expected to drive market growth. For instance, as per an article published in August 2022 in PubMed, longitudinal indirect calorimeter (IC) measurements taken before, during, and after ICU care may be needed to become the new global standard of care for directing nutritional care given recent advancements in IC technologies and the widespread availability of a new generation of IC equipment.
Hence, due to the increase in obesity cases and the rise in technological advancements in indirect calorimeters, the market studied is expected to witness growth over the forecast period. However, the high cost of the devices and stringent regulatory guidelines are likely to restrain market growth over the forecast period.
Indirect Calorimeter Market Trends
Hospital Segment Expected to Hold a Significant Market Share Over the Forecast Period
The hospital segment is anticipated to witness growth in the market studied. Indirect calorimetry measures the gases in the air one exhales as a way to determine how many calories one's body burns at rest. Indirect calorimetry (IC) is the gold standard for evaluating calorie needs.
IC is mostly used for all the patients of a tertiary care hospital, with more emphasis on patients with obesity-related records. IC can be used to target nutritional goals, as both protein and AC/REE (administered calories to resting energy expenditure ratio) show a trend toward higher survival at the cost of increased length of stay.
For instance, as per an article published in September 2022 in the Multidisciplinary Digital Publishing Institute (MDPI) Journal, the most precise method of calculating energy expenditure is indirect calorimetry, which gauges carbon dioxide and oxygen concentrations during inspiration and expiration. In intensive care units (ICUs), this method is now advised as the gold standard for determining energy needs.
Furthermore, as per an article published in May 2022 in BioMed Central’s (BMC) journal, when energy objectives were based on IC, short-term mortality decreased by 23%. As per the same source, routine use of indirect calorimetry in critically ill patients showed potential improvements in the outcome with indirect calorimetry-guided nutrition therapy. Hence, the increase in advantages offered by IC alone and in combination are expected to boost the segment’s growth over the forecast period. Similarly, as per the article published in September 2022 in Springer, critically injured trauma patients found that ongoing IC led to better, more personalized care that took into account changing metabolic dynamics over time.
Hence, due to the increase in advantages offered by IC in critically ill patients in hospital settings and the rise in demand for IC compared to direct calorimetry, the segment studied is expected to witness growth over the forecast period.
North America Expected to Hold a Significant Market Share Over the Forecast Period
North America is expected to hold a significant share of the market due to the increasing obese population across the region and the availability of better healthcare infrastructure, coupled with rising awareness about facilities available for obese people.
For instance, as per the World Obesity Atlas 2022, the estimated adult prevalence is likely to be 46.9% in the United States by 2030. As per the same source, the estimated population of women above the body mass index of 30 kg is likely to be 6,271,328 by 2030 in Canada. Hence, the rise in obesity cases across regional countries is expected to increase the demand for calorie-deficit lifestyles and calorie measurements, which are likely to boost market growth over the forecast period.
Furthermore, as per an article published in November 2022 in Cell Report, researchers assessed the impact of dietary alteration to a high-fat diet (HFD) on the intestine. A significant change in diet over time can affect metabolism and physiology. In the United States, a caloric imbalance may be one factor contributing to obesity. The article demonstrated an increased chance of adopting indirect calorimeters across North American countries due to the population’s high risk of obesity.
Hence, due to the increase in the obese population and rise in product launches, North America is expected to hold a significant market share over the forecast period.
Indirect Calorimeter Industry Overview
The indirect calorimeter market is moderately competitive and consists of a few major players. A forerunner in the field of calorimetry with world-leading products in calorimetry and artificial environment control rooms, Fuji Medical Science recently intensified R&D collaboration in East Asia to break new ground in the treatment of aging and lifestyle diseases. Companies like Cosmed SRL, KORR Medical Technologies, Maastricht Instruments BV, MGC Diagnostics, Parvo Medics, and Vyaire Medical hold a substantial share of the market.
Indirect Calorimeter Market Leaders
-
KORR Medical Technologies
-
Parvo Medics
-
Cosmed srl
-
MGC Diagnostics
-
Vyaire Medical
*Disclaimer: Major Players sorted in no particular order
Indirect Calorimeter Market News
- September 2022: Halton Healthcare's Oakville Trafalgar Memorial Hospital (OTMH) became the first hospital in Ontario to have a Q-NRG+ Indirect Calorimeter machine. The machine uses new technologies to measure the levels of oxygen and carbon dioxide in a patient's breath and determine their resting energy expenditure (REE).
- August 2021: The University of Liege sponsored a clinical study to assess the comparison of indirect calorimetry by Q-NRG (Cosmed) with Deltatrac II (Datex).
Indirect Calorimeter Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancements in Indirect Calorimeters
4.2.2 Rising Prevalence of Obesity
4.3 Market Restraints
4.3.1 Stringent Regulatory Guidelines and High Cost of Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Type
5.1.1 Standalone
5.1.2 Portable
5.2 By End User
5.2.1 Hospitals
5.2.2 Diagnostic Centers
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Rest of Asia-Pacific
5.3.4 Rest of the World
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Cosmed SRL
6.1.2 KORR Medical Technologies
6.1.3 Maastricht Instruments BV
6.1.4 MGC Diagnostics
6.1.5 TSE Systems
6.1.6 Summit Healthcare (P) Ltd
6.1.7 Parvo Medics
6.1.8 Vyaire Medical
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Indirect Calorimeter Industry Segmentation
As per the scope of the report, indirect calorimeters refer to devices that use the reference standard and clinically recommended means to measure energy expenditure. Indirect calorimetry is nothing but a type of whole-body calorimetry where all gas consumption and gas exhalation are continuously monitored. It can be used to determine energy expenditure through the use of equations relating to total O2 consumption, CO2 expiration, and urinary nitrogen excretion to energy utilization.
The indirect calorimeter market is segmented by type, end user, and geography. By type, the market is segmented into standalone and portable. By end user, the market is segmented into hospitals, diagnostic centers, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
The report offers the market sizes and forecasts in value terms (USD) for the above segments.
| By Type | |
| Standalone | |
| Portable |
| By End User | |
| Hospitals | |
| Diagnostic Centers | |
| Other End Users |
| Geography | |||||||
| |||||||
| |||||||
| |||||||
| Rest of the World |
Indirect Calorimeter Market Research FAQs
What is the current Indirect Calorimeter Market size?
The Indirect Calorimeter Market is projected to register a CAGR of 5% during the forecast period (2024-2029)
Who are the key players in Indirect Calorimeter Market?
KORR Medical Technologies, Parvo Medics, Cosmed srl, MGC Diagnostics and Vyaire Medical are the major companies operating in the Indirect Calorimeter Market.
Which is the fastest growing region in Indirect Calorimeter Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Indirect Calorimeter Market?
In 2024, the North America accounts for the largest market share in Indirect Calorimeter Market.
What years does this Indirect Calorimeter Market cover?
The report covers the Indirect Calorimeter Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Indirect Calorimeter Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Indirect Calorimeter Industry Report
Statistics for the 2024 Indirect Calorimeter market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Indirect Calorimeter analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
